Loading ...

Sadeed Rashid

Immune Tolerance Network

Research Data Manager

Assessment Group

srashid@immunetolerance.org

Work:

Mobile:

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN062ST

-

Tolerance by engaging antigen during cellular homeostasis

ITN066AI

-

Type 1 Diabetes Extension Study

ITN070AD

-

ITN073ST

-

Liver Transplantation with Tregs at MGH

ITN075AI

-

Brentuximab Vedotin for Systemic Sclerosis

ITN077AI

-

Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

ITN079AD

-

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

ITN080AI

-

Belimumab With Rituximab for Primary Membranous Nephropathy

ITN084AD

-

Grass Pollen Immunotherapy plus Dupilumab for Tolerance Induction

ITN086AI

-

Evaluation of AMG 714 for Vitiligo

ITN089ST

-

Carfilzomib and Belatacept for Desensitization

ITN090ST

-

Daratumumab and Belatacept for Desensitization

ITN091AI

-

VIBRANT: VIB4920 for Active Lupus Nephritis

ITN093AI

-

Daratumumab in Primary Antiphospholipid Syndrome

ITN095AI

-

Siplizumab in T1DM

ITN097AD

-

Efficacy of Tezepelumab in Peanut Allergy

ITN100ST

-

Siplizumab for Liver Transplant Tolerance

ITN101ST

-

EVR and EPO for Liver Transplant Tolerance

ITN103AI

-

Targeting IL-7Rα in Vitiligo

ITN104AI

-

TYK2i in Type 1 Diabetes

ITN830AI

-

DSG3-CAART for anti-DSG3 pemphigus vulgaris

ITN832AI

-

Clinical phase II/III trial of Ustekinumab to treat type 1 diabetes.

ITN833AD

-

Bio:

Admin Links

Shortcuts

ITN Documents

Links